Karwan Moutasim
Karwan Moutasim
Clinical Lecturer in Pathology, University of Southampton
Email verificata su soton.ac.uk - Home page
Titolo
Citata da
Citata da
Anno
Stromal features are predictive of disease mortality in oral cancer patients
D Marsh, K Suchak, KA Moutasim, S Vallath, C Hopper, W Jerjes, T Upile, ...
The Journal of pathology 223 (4), 470-481, 2011
2622011
Betel‐derived alkaloid up‐regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis
KA Moutasim, V Jenei, K Sapienza, D Marsh, PH Weinreb, SM Violette, ...
The Journal of pathology 223 (3), 366-377, 2011
892011
Upregulation of Eps8 in oral squamous cell carcinoma promotes cell migration and invasion through integrin-dependent Rac1 activation
LF Yap, V Jenei, CM Robinson, K Moutasim, TM Benn, SP Threadgold, ...
Oncogene 28 (27), 2524-2534, 2009
852009
Cell migration and invasion assays
KA Moutasim, ML Nystrom, GJ Thomas
Cancer cell culture, 333-343, 2011
612011
Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4
CJ Hanley, M Mellone, K Ford, SM Thirdborough, T Mellows, SJ Frampton, ...
JNCI: Journal of the National Cancer Institute 110 (1), 109-120, 2018
552018
Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis
M Mellone, CJ Hanley, S Thirdborough, T Mellows, E Garcia, J Woo, ...
Aging (Albany NY) 9 (1), 114, 2017
462017
A comparison of primary oesophageal squamous epithelial cells with HET‐1A in organotypic culture
TJ Underwood, MF Derouet, MJ White, F Noble, KA Moutasim, E Smith, ...
Biology of the Cell 102 (12), 635-644, 2010
372010
Association between miR-31-3p expression and cetuximab efficacy in patients with KRAS wild-type metastatic colorectal cancer: a post-hoc analysis of the New EPOC trial
S Pugh, R Thiébaut, J Bridgewater, ML Grisoni, K Moutasim, F Rousseau, ...
Oncotarget 8 (55), 93856, 2017
302017
Orofacial presentations of sarcoidosis–a case series and review of the literature
TWJ Poate, R Sharma, KA Moutasim, MP Escudier, S Warnakulasuriya
British dental journal 205 (8), 437-442, 2008
252008
In vitro effect of bisphosphonates on oral keratinocytes and fibroblasts
NMH McLeod, KA Moutasim, PA Brennan, G Thomas, V Jenei
Journal of Oral and Maxillofacial Surgery 72 (3), 503-509, 2014
222014
Evaluating the effect of immune cells on the outcome of patients with mesothelioma
SJ Chee, M Lopez, T Mellows, S Gankande, KA Moutasim, S Harris, ...
British journal of cancer 117 (9), 1341-1348, 2017
202017
A case of vulvovaginal gingival lichen planus in association with Good’s syndrome
KA Moutasim, TWJ Poate, JF Setterfield, SJ Challacombe
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and …, 2008
202008
Pro‐migratory and TGF‐β‐activating functions of αvβ6 integrin in pancreatic cancer are differentially regulated via an Eps8‐dependent GTPase switch
J Tod, CJ Hanley, MR Morgan, M Rucka, T Mellows, MA Lopez, P Kiely, ...
The Journal of pathology 243 (1), 37-50, 2017
172017
Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays
J Lawson, RJ Robinson-Vyas, JP McQuillan, A Paterson, S Christie, ...
British journal of cancer 116 (2), 237-245, 2017
142017
GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state
SK Nadendla, A Hazan, M Ward, LJ Harper, K Moutasim, LS Bianchi, ...
PLoS One 6 (5), e20271, 2011
132011
HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma
JC Fleming, J Woo, K Moutasim, M Mellone, SJ Frampton, A Mead, ...
British journal of cancer 120 (3), 356-367, 2019
122019
Assessment of nuclear ZEB2 as a biomarker for colorectal Cancer outcome and TNM risk stratification
R Sreekumar, S Harris, K Moutasim, R DeMateos, A Patel, K Emo, ...
JAMA network open 1 (6), e183115-e183115, 2018
92018
Human papillomavirus testing in diagnostic head and neck histopathology
KA Moutasim, M Robinson, S Thavaraj
Diagnostic Histopathology 21 (2), 77-84, 2015
82015
Breast cancer in patients with germline TP53 pathogenic variants have typical tumour characteristics: the Cohort study of TP53 carrier early onset breast cancer …
K Packwood, G Martland, M Sommerlad, E Shaw, K Moutasim, G Thomas, ...
The Journal of Pathology: Clinical Research 5 (3), 189-198, 2019
72019
Suppression of Hedgehog signalling promotes pro‐tumourigenic integrin expression and function
KA Moutasim, T Mellows, M Mellone, MA Lopez, J Tod, PC Kiely, ...
The Journal of Pathology 233 (2), 196-208, 2014
72014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20